THE REPUBLIC OF GEORGIA is the location of ROW’s latest equipment grant. Georgia shares a border with Armenia, the location of our very first grant in 2015. Now we’re providing the same Natus Neurology 32-channel video EEG workstation to the Georgian League Against Epilepsy. It will be placed at the Institute for Neurology and Neuropsychology in the capital city of Tbilisi. The city is home to more than 1.1 million people, about a third of the nation’s population.
The EEG machine will be available to patients at the Institute. The video capabilities allow for in-depth testing and more accurate diagnosis for new patients and for those with drug-resistant epilepsies.
This EEG machine will be under the supervision of Dr. Giorgi Lomidze. He and other members of the International Bureau for Epilepsy conducted a study in 2012 that found an active epilepsy rate in Georgia of 8.8 per 1000. They also uncovered a treatment gap of about 66%. They hoped the findings would inform future planning of epilepsy care in Georgia. ROW’s latest grant is one part of realizing that hope.
This month we sent four cases of Roweepra® to Solidarity Bridge for Bolivia, where about 12% of the population experiences seizures at some point in their lives. The great majority have little access to treatment. Earlier this year, a team from Solidarity Bridge helped celebrate the opening of Bolivia’s first comprehensive epilepsy center at Belga Hospital in Cochabamba. We plan to provide ongoing medication grants through Solidarity Bridge as their work expands.
Our partner, OWP PHARMACEUTICALS donated more than $500,000 worth of Roweepra® to DirectRelief to be distributed in under-resourced communities. OWP is nearing $3 million in medical donations in keeping with its mission to provide resources for those living with epilepsy and associated psychiatric disorders in underresourced areas around the world.